Skip to content
Care, coaching and clear next steps.
I start here!
Menu
← All articles

Longevity evidence

NAD Injections and IV Therapy: Evidence, Risks and Claims

Learn what NAD+ is, what human injection and infusion studies actually measure, and why biomarker changes do not prove anti-aging or energy benefits.

Educational content. Clinical review pending. How we prepare our guides

NAD+ injections and IV therapy have not been established by the human studies reviewed here as treatments that extend lifespan or reverse aging. The cited research examines metabolism, tolerability or blood measurements. Those outcomes do not demonstrate the broad energy and longevity benefits often advertised. Infusion pilot, 2026 tolerability study

Before comparing clinics or packages, separate what the molecule does in the body from what an administered product has been shown to do for a patient.

Is NAD+ a peptide?

No. NAD stands for nicotinamide adenine dinucleotide. It is a coenzyme involved in cellular metabolism, not a chain of amino acids. “NAD peptide” is a search term or marketing description, not the correct molecule classification. NAD research background

NAD+, its reduced form NADH, and precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are related but distinct. Findings about one ingredient or delivery route should not silently become evidence for another. Our peptide explainer shows why identifying the molecule matters.

What have human IV studies measured?

Research What was studied What it does not establish
2019 pilot Changes in NAD-related compounds in blood and urine during and after an infusion Longer life, improved daily function or durable relief of fatigue
2026 retrospective pilot Tolerability and short-term measurements in clients receiving NAD+ or NR infusions Long-term safety or a proven anti-aging treatment

The 2026 study reviewed records from a commercial wellness setting. NAD+ recipients reported gastrointestinal symptoms, increased heart rate and chest pressure during infusions. The design was retrospective, the follow-up was short, and the authors included people affiliated with the business. It cannot replace randomized trials measuring meaningful health outcomes. Study details

An IV study also does not validate a self-injected product, a different formulation or a home dosing schedule. Those would need their own evidence.

Does a low NAD blood result show you need treatment?

That conclusion is not established. A 2026 study across seven human cohorts found whole-blood NAD+ levels remained broadly stable with age and lifestyle interventions, challenging their use as an aging biomarker. It does not answer every question about NAD in different tissues, but it makes a simple “older age means low blood NAD” sales claim harder to justify. Nature Metabolism study

If testing is offered, ask what the result predicts, what validated threshold would change care and whether treating that number improves an outcome you can feel or measure meaningfully.

What are the safety concerns?

FDA has warned about inappropriate food-grade NAD+ ingredients being used for sterile products. The agency received reports including severe chills, shaking, vomiting and fatigue, sometimes requiring medical treatment; it describes these reactions as consistent with excessive endotoxins. FDA alert

“Naturally present in the body” does not establish that an injected preparation is sterile, correctly made or safe. Compounded drugs are not FDA approved and do not undergo the same premarket evaluation for quality, safety and effectiveness. FDA compounding explanation

Severe symptoms during or after an infusion need medical assessment. Chest pain, breathing difficulty or collapse require urgent care; they should not be dismissed as evidence that a treatment is “detoxing” you.

What should you ask before paying?

  • Which exact ingredient, formulation and route are being offered?
  • What human study supports the benefit being promised?
  • Did that study measure symptoms or health outcomes, or only a laboratory marker?
  • Who prescribes and administers it, and how are adverse reactions managed?
  • What pharmacy prepares it and what approval status applies to the exact product?
  • What is the full cost, including repeat sessions and testing?

If low energy is the reason you are considering NAD, ask for an assessment of the symptom itself. An infusion package should not substitute for understanding persistent fatigue. Pephelp’s wellness content is educational and does not represent an offer of NAD treatment.

Sources and further reading

  1. Grant et al., 2019: NAD metabolite changes during a six-hour IV infusion (opens in a new tab)
  2. Reyna et al., 2026: retrospective NAD+ and NR infusion tolerability study (opens in a new tab)
  3. Trętowicz et al., 2026: whole-blood NAD+ levels and age (opens in a new tab)
  4. FDA: ingredients suitable for sterile compounding and NAD+ adverse-event reports (opens in a new tab)
  5. FDA: understanding the risks of compounded drugs (opens in a new tab)

Source review October 17, 2026. Individual checks may be dated in the article. Prices, labels and policies can change. Linked studies being peer reviewed does not mean this article has been clinically reviewed.

Your next step with Pephelp

Make room for feeling more like you.

Tell us about your priorities and explore a clinical wellness review.

Start my wellness quiz

US care · Clinical review before treatment

Compare plans and prices